One of the deadliest infectious diseases can be difficult to treat because of drug-resistant strains. But with a new study, scientists from a group of institutions including Scripps Research in La Jolla say they are seeing a promising new treatment option emerge for tuberculosis.

The study, led by Texas A&M University’s Department of Biochemistry and Biophysics and Scripps Research’s Calibr-Skaggs Institute for Innovative Medicines , was released July 30 in the scientific journal Nature .

More than 40 authors are listed on the paper, including scientists from Weill Cornell Medicine, Rutgers University, Colorado State University and Shanghai Jiao Tong University’s Institute of Translational Medicine.

Central to the group’s discoveries is the development of a new compound called C

See Full Page